Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:264-269
Published online before print December 11, 2003, doi: 10.1161/01.ATV.0000112036.72200.ac
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
24/2/264    most recent
01.ATV.0000112036.72200.acv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kolmakova, A.
Right arrow Articles by Chatterjee, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kolmakova, A.
Right arrow Articles by Chatterjee, S.
Related Collections
Right arrow Lipid and lipoprotein metabolism
Right arrow Other Vascular biology
Right arrow Apoptosis
Right arrow Pathophysiology
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:264.)
© 2004 American Heart Association, Inc.


Vascular Biology

Apolipoprotein C-I Induces Apoptosis in Human Aortic Smooth Muscle Cells via Recruiting Neutral Sphingomyelinase

Antonina Kolmakova; Peter Kwiterovich; Donna Virgil; Petar Alaupovic; Carolyn Knight-Gibson; Sergio F. Martin; Subroto Chatterjee

From the Lipid Research Atherosclerosis Division (A.K., P.K., D.V., S.F.M., S.C.) and the Department of Pediatrics (S.C.), Johns Hopkins University, Baltimore, MD; and the Oklahoma Medical Research Foundation (P.A., C.K.-G.), Oklahoma City, OK.

Correspondence to Subroto Chatterjee, 550 North Broadway, Suite 312, Baltimore, MD 21205. E-mail schatte2{at}jhmi.edu

Objectives— Apolipoprotein C-I (apoC-I) influences lipoprotein metabolism, but little is known about its cellular effects in aortic smooth muscle cells (ASMC).

Methods and Results— In cultured human ASMC, apoC-I and immunoaffinity purified apoC-I–enriched high-density lipoproteins (HDL) markedly induced apoptosis (5- to 25-fold), compared with control cells, apoC-I–poor HDL, and apolipoprotein C-III (apoC-III) as determined by 4', 6-diamidino-2-phenylindole dihydrochloride staining and DNA ladder assay. Preincubation of cells with GW4869, an inhibitor of neutral sphingomyelinase (N-SMase), blocked apoC-I–induced apoptosis, an effect that was bypassed by C-2 ceramide. The activity of N-SMase was increased 2- to 3-fold in ASMC by apoC-I, apoC-I–enriched HDL, and tumor necrosis factor {alpha} (TNF-{alpha}) (positive control) after 10 minutes and then decreased over 60 minutes, which is a kinetic pattern not seen with controls, apoC-III, and apoC-I–poor HDL. ApoC-I and apoC-I–enriched HDL stimulated the generation of ceramide, the release of cytochrome c from mitochondria, and activation of caspase-3 greater than that found in controls, apoC-III, and apoC-I–poor HDL. GW4869 inhibited apoC-I–induced production of ceramide and cytochrome c release.

Conclusions— ApoC-I and apoC-I–enriched HDL activate the N-SMase-ceramide signaling pathway, leading to apoptosis in human ASMC, which is an effect that may promote plaque rupture in vivo.


Key Words: apolipoprotein C-I • apoptosis • sphingomyelinase • high-density lipoproteins • tumor necrosis factor-{alpha}




This article has been cited by other articles:


Home page
Biophys. JHome page
V. M. Bolanos-Garcia, A. Renault, and S. Beaufils
Surface Rheology and Adsorption Kinetics Reveal the Relative Amphiphilicity, Interfacial Activity, and Stability of Human Exchangeable Apolipoproteins
Biophys. J., March 1, 2008; 94(5): 1735 - 1745.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Westerterp, J. F.P. Berbee, N. M.M. Pires, G. J.D. van Mierlo, R. Kleemann, J. A. Romijn, L. M. Havekes, and P. C.N. Rensen
Apolipoprotein C-I Is Crucially Involved in Lipopolysaccharide-Induced Atherosclerosis Development in Apolipoprotein E Knockout Mice
Circulation, November 6, 2007; 116(19): 2173 - 2181.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
P. O. Kwiterovich Jr, S. L. Cockrill, D. G. Virgil, E. S. Garrett, J. Otvos, C. Knight-Gibson, P. Alaupovic, T. Forte, L. Zhang, Z. N. Farwig, et al.
A Large High-Density Lipoprotein Enriched in Apolipoprotein C-I: A Novel Biochemical Marker in Infants of Lower Birth Weight and Younger Gestational Age
JAMA, April 20, 2005; 293(15): 1891 - 1899.
[Abstract] [Full Text] [PDF]